Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Surgery for T4 Colorectal Cancer in Older Patients: Determinants of Outcomes
Michael Osseis, William A Nehmeh, Nathalie Al Rassy, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 9, pp. 1534-1534
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Clinicopathological features of Lynch syndrome pedigrees with MSH2 c.351G>A gene variant
Shuai Zhang, Guanyu Fu, Gongping Sun, et al.
Molecular Genetics & Genomic Medicine (2025) Vol. 13, Iss. 1
Open Access | Times Cited: 1
The Emerging Role of Blood-Based Biomarkers in Early Detection of Colorectal Cancer: A Systematic Review
Faris Shweikeh, Yuhao Zeng, Abdur Rahman Jabir, et al.
Cancer Treatment and Research Communications (2025), pp. 100872-100872
Open Access | Times Cited: 1
Mutational and Co-Mutational Landscape of Early Onset Colorectal Cancer
Jumanah Alshenaifi, Guglielmo Vetere, Giulia Maddalena, et al.
Biomarkers (2025), pp. 1-13
Closed Access
Zinc Finger Proteins in Colorectal Cancer: Insights into Molecular Mechanisms and Therapeutic Implications
Chongyuan Lan, Ming Qiu, Minglin Lin
Technology in Cancer Research & Treatment (2025) Vol. 24
Open Access
The Role of Proteomics and Genomics in the Development of Colorectal Cancer Diagnostic Tools and Potential New Treatments
Gaurav Paraskar, Sankha Bhattacharya, Kuttiappan Anitha
ACS Pharmacology & Translational Science (2025)
Closed Access
Albumin-bilirubin score: a promising predictor of postoperative distant metastasis in patients with colorectal cancer
Xiuying Shi, Shuyi Zhang, Baijun Bao, et al.
Biomarkers in Medicine (2025), pp. 1-7
Closed Access
A Case Study on Complete Pathological Response in Advanced Rectal Cancer Patient with Oxaliplatin-based Chemotherapy without Cumulative Neurotoxicity
Rehab A. M Jawad, Bahir Abdul Razzaq Mshimesh, Qasim S. Al‐Mayah, et al.
Journal of Gastrointestinal Cancer (2025) Vol. 56, Iss. 1
Closed Access
KRAS/NRAS Mutations Associated with Distant Metastasis and BRAF/PIK3CA Mutations Associated with Poor Tumor Differentiation in Colorectal Cancer
Juanzi Zeng, Wenwei Fan, Jiaquan Li, et al.
International Journal of General Medicine (2023) Vol. Volume 16, pp. 4109-4120
Open Access | Times Cited: 10
Veliparib (ABT-888), a PARP inhibitor potentiates the cytotoxic activity of 5-fluorouracil by inhibiting MMR pathway through deregulation of MSH6 in colorectal cancer stem cells
Subarno Paul, Subhajit Chatterjee, Saptarshi Sinha, et al.
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 10, pp. 999-1015
Closed Access | Times Cited: 9
Prognostic value of dynamic changes of pre- and post-operative tumor markers in colorectal cancer
Guangming Ren, Gaozan Zheng, Kunli Du, et al.
Clinical & Translational Oncology (2024) Vol. 26, Iss. 8, pp. 2047-2059
Closed Access | Times Cited: 3
Evaluation of ctDNA in the Prediction of Response to Neoadjuvant Therapy and Prognosis in Locally Advanced Rectal Cancer Patients: A Prospective Study
Marina Morais, Telma Fonseca, D Melo Pinto, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 3, pp. 427-427
Open Access | Times Cited: 8
The Association of Inflammatory Related Markers with the Prognosis in Elderly Patients with Colorectal Cancer
Shih Wei Chiang
Cancer Management and Research (2024) Vol. Volume 16, pp. 37-48
Open Access | Times Cited: 2
The efficacy-associated biomarkers for immune checkpoint inhibitors in gastrointestinal cancer: a literature review
Peixi Zhao, Rui Jin, Bin Zhao, et al.
Journal of Gastrointestinal Oncology (2024) Vol. 15, Iss. 1, pp. 514-528
Open Access | Times Cited: 2
Seed and Soil: Consensus Molecular Subgroups (CMS) and Tumor Microenvironment Features Between Primary Lesions and Metastases of Different Organ Sites in Colorectal Cancer
Qingqing Luo, Yibo Quan, Wei Liu, et al.
Cancer Management and Research (2024) Vol. Volume 16, pp. 225-243
Open Access | Times Cited: 2
The cost-effectiveness analysis of serplulimab versus regorafenib for treating previously treated unresectable or metastatic microsatellite instability-high or deficient mismatch repair colorectal cancer in China
Yue Ma, Jiting Zhou, Yuxin Ye, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 5
HNRNPA2B1-Mediated MicroRNA-92a Upregulation and Section Acts as a Promising Noninvasive Diagnostic Biomarker in Colorectal Cancer
Yiling Li, Kexin Li, Xiaoying Lou, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1367-1367
Open Access | Times Cited: 4
Regulation and function of the RSK family in colorectal cancer
Ziyi Wang, Xiangming Han, Zhe Lei, et al.
Journal of Cancer Metastasis and Treatment (2024)
Open Access | Times Cited: 1
GLR in Colorectal Cancers: An Easily Accessible Prognostic Marker
İsa Caner Aydın, İsmail Ege Subaşı, Ahmet Orhan Sunar, et al.
International Journal of General Medicine (2024) Vol. Volume 17, pp. 2361-2369
Open Access | Times Cited: 1
Revolutionizing prognostic predictions in colorectal cancer: Macrophage‑driven transcriptional insights from single‑cell RNA sequencing and gene co‑expression network analysis
Yang Feng, Zhuo Cheng, Jingyuan Gao, et al.
Oncology Letters (2024) Vol. 28, Iss. 6
Open Access | Times Cited: 1
Forkhead box D subfamily genes in colorectal cancer: potential biomarkers and therapeutic targets
Ying Chen, Haiyan Qiao, Ruiqi Zhong, et al.
PeerJ (2024) Vol. 12, pp. e18406-e18406
Open Access | Times Cited: 1
Molecular Biology of Cancer—Interplay of Malignant Cells with Emerging Therapies
Stergios Boussios, Matin Sheriff, Saak V. Ovsepian
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 13090-13090
Open Access | Times Cited: 1
Peptidomic changes in human serous colorectal cancer patients
Jianghao Xu, Xingling Li, Wenlong Chen, et al.
Journal of Gastrointestinal Oncology (2023) Vol. 14, Iss. 2, pp. 705-718
Open Access | Times Cited: 3
Neoadjuvant Chemoradiation for Rectal Cancer Achieves Satisfactory Tumour Regression and Local Recurrence – Result of a Dedicated Multi-disciplinary Approach from a South Asian Centre
Raeed Deen, Dileepa Senajith Ediriweera, Suchintha Thillakaratne, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Exploration into Plasma Hsa_circ_0052184 as a New Biomarker of Colorectal Cancer Prognosis
Enqi Zheng, Deshuang Xiao
Pharmacogenomics and Personalized Medicine (2023) Vol. Volume 16, pp. 589-597
Open Access | Times Cited: 3
Outcomes of preoperative chemotherapy for colorectal cancer with peritoneal metastasis underwent cytoreductive surgery
Binying Peng, Zhiying Liu, Binjie Huang, et al.
Clinical & Translational Oncology (2023) Vol. 26, Iss. 1, pp. 269-277
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top